ArticleBreast cancer research : BCR2005
Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours.
Jill E Kucab et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it